Stock listing

OTC:BRGX BioRegenx, Inc Stock

Follow BioRegenx, Inc into a list and get an email when it puts out news.

Share price · OTC:BRGX

$0.0002 USD 0.0000 (0.0%)

Close on Oct 30, 2026

Past year -97.7% · daily closes, Oct 30, 2025 – Oct 30, 2026, adjusted for splits
Day range
$0.0002 – $0.0002 USDOct 30, 2026
Market cap
$194,315 USDAt the close on Oct 30, 2026 · price × 971.6M shares outstanding
52-week range
$0.0002 – $0.0240 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
Traded on an average day
$263 USDMedian day 0 shares · 37 days with no trades · last 3 months, Jul 30, 2026 – Oct 30, 2026
BioRegenx, Inc logo

Daily closes

Last 3 months, Jul 30, 2026 – Oct 30, 2026 · OTC:BRGX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.000212,500
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.0002300,000
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0005$0.000217,600
$0.0002-0.0038-95.0%$0.0002$0.0002$0.00025,000
$0.00400.00000.0%$0.0040$0.0040$0.00400
$0.00400.00000.0%$0.0040$0.0040$0.00400
$0.00400.00000.0%$0.0040$0.0040$0.00400
$0.00400.00000.0%$0.0040$0.0040$0.00400
$0.0040-0.0010-20.0%$0.0040$0.0040$0.004074,222
$0.0050+0.0020+66.7%$0.0030$0.0050$0.0030351,164
$0.00300.00000.0%$0.0030$0.0030$0.00300
$0.0030-0.0015-33.3%$0.0030$0.0030$0.003070,765
$0.0045+0.0015+50.0%$0.0050$0.0050$0.0045800,000
$0.0030-0.0058-65.9%$0.0040$0.0040$0.003017,500
$0.0088+0.0043+95.6%$0.0088$0.0088$0.008860,213
$0.0045+0.0005+12.5%$0.0040$0.0045$0.004041,755
$0.0040+0.0005+14.3%$0.0040$0.0040$0.0037180,000
$0.0035-0.0005-12.5%$0.0030$0.0035$0.0030141,878
$0.0040-0.0015-27.3%$0.0050$0.0052$0.0030198,000
$0.00550.00000.0%$0.0055$0.0055$0.00550
$0.00550.00000.0%$0.0055$0.0055$0.00550
$0.00550.00000.0%$0.0055$0.0055$0.00550
$0.0055-0.0010-15.4%$0.0055$0.0055$0.0055225
$0.00650.00000.0%$0.0065$0.0065$0.00650
$0.00650.00000.0%$0.0065$0.0065$0.00650
$0.00650.00000.0%$0.0065$0.0065$0.00650
$0.0065+0.0005+8.3%$0.0060$0.0065$0.006075,000
$0.0060-0.0010-14.3%$0.0060$0.0060$0.006075,002
$0.00700.00000.0%$0.0070$0.0070$0.00700
$0.0070+0.0025+55.6%$0.0070$0.0070$0.0070100
$0.00450.00000.0%$0.0045$0.0045$0.0045100,000
$0.0045-0.0007-13.5%$0.0056$0.0056$0.0030394,555
$0.00520.00000.0%$0.0052$0.0052$0.00520
$0.00520.00000.0%$0.0052$0.0052$0.00520
$0.00520.00000.0%$0.0052$0.0052$0.00520
$0.0052-0.0003-5.5%$0.0055$0.0055$0.0025138,188
$0.0055-0.0025-31.3%$0.0051$0.0055$0.0050355,500
$0.00800.00000.0%$0.0080$0.0080$0.00800
$0.00800.00000.0%$0.0080$0.0080$0.00800
$0.00800.00000.0%$0.0080$0.0080$0.00800
$0.00800.00000.0%$0.0080$0.0080$0.00800
$0.00800.00000.0%$0.0065$0.0080$0.006390,000
$0.00800.00000.0%$0.0080$0.0080$0.00800
$0.0080+0.0015+23.1%$0.0080$0.0080$0.0075227,390
$0.0065+0.0005+8.3%$0.0065$0.0065$0.00652,000
$0.00600.00000.0%$0.0060$0.0060$0.00600
$0.00600.00000.0%$0.0060$0.0060$0.00600
$0.00600.00000.0%$0.0060$0.0060$0.00600
$0.00600.00000.0%$0.0060$0.0060$0.00600
$0.00600.00000.0%$0.0060$0.0060$0.00600
$0.0060+0.0005+9.1%$0.0060$0.0060$0.00606,578
$0.0055-0.0005-8.3%$0.0055$0.0055$0.005510,000
$0.0060-0.0010-14.3%$0.0069$0.0069$0.006015,002
$0.00700.00000.0%$0.0070$0.0070$0.00700
$0.00700.00000.0%$0.0070$0.0070$0.00700
$0.00700.00000.0%$0.0070$0.0070$0.00700
$0.0070-0.0005-6.7%$0.0060$0.0070$0.00607,750
$0.00750.00000.0%$0.0075$0.0075$0.00750
$0.00750.00000.0%$0.0075$0.0075$0.00750
$0.00750.00000.0%$0.0075$0.0075$0.00750
$0.00750.00000.0%$0.0075$0.0075$0.00750
$0.00750.00000.0%$0.0075$0.0075$0.00750
$0.00750.00000.0%$0.0075$0.0075$0.00750

Splits

6 splits since 2002 · OTC:BRGX · every price before a split is adjusted for it

DayRatioWhat
1-for-30Consolidation
1-for-100Consolidation
3-for-1Split
1-for-15Consolidation
1-for-5Consolidation
1-for-3Consolidation
Ticker
OTC:BRGX
Asset type
Stock
Exchange
OTC
Currency
USD

What changed lately

Latest news

All BioRegenx, Inc news

BioRegenx, Inc on 6ix

News releases
1 in the last 12 months · 197 in all · newest Dec 9, 2025 · oldest 2019

Valuation

Statements: 4 quarters to Mar 31, 2026 · price Oct 30, 2026

Enterprise value
$2.31M USD
P/E
Loss
EV/sales
1.3×
EV/EBITDA
Negative EBITDA
Price/book
Negative equity
Gross margin
81.9%
Operating margin
−62.4%
Net margin
−73.8%
Debt to equity
Negative equity
Beta vs S&P 500
-0.20

Team and board

Officers

OfficerRole
Diane BouisActing CEO MVHS
William ResidesCHIEF EXECUTIVE OFFICER AND CHAIRMAN OF THE BOARD, BIOREGENX AND NULIFE SCIENCES & DIRECTOR
Richard JanneyStrategic CFO & Board Member
Gary HennerbergSecretary

Board

DirectorRole
William ResidesCHIEF EXECUTIVE OFFICER AND CHAIRMAN OF THE BOARD, BIOREGENX AND NULIFE SCIENCES & DIRECTOR
Richard JanneyStrategic CFO & Board Member
Suzanne BirdDirector
Thomas PowersDirector

Events

QuarterResultsShare move
Q3 2025Nov 14, 2025−54.2%
Q2 2025Aug 14, 2025−23.5%
Q1 2025May 21, 2025 · After close−25.9%
Q3 2024Nov 18, 2024 · After close+4.0%
Q1 2024May 23, 2024 · After close+40.7%

Open Events

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2015
Revenue1.85M2.34M3.41M42.2K198.6K404.4K478.1K257.9K268.5K343.7K
Cost of revenue350.9K681.7K1.10M055445.0K213.1K1.41K
Gross profit1.50M1.66M2.31M42.2K198.0K359.4K265.0K256.5K
Research and development31.8K0257.7K1.18M317.6K
Selling, general and administrative2.01M5.85M5.23M55.6K147.7K132.6K467.1K290.7K
Operating income-1.24M-22.8M-3.41M-78.3K-165.1K-216.0K-210.0K-47.3K-74.1K12.0K
Depreciation and amortization75.1K2.22M4.77K5.93K4.45K5.93K5.93K5.93K
EBITDA-1.17M-20.5M-3.40M-72.4K-160.7K-210.1K-204.1K-41.4K
Interest expense299.6K290.7K292.2K07.28K2.57K
Income before tax-1.54M-23.1M-1.28M-78.3K-96.9K-274.0K-208.0K-47.3K-81.4K9.42K
Income tax00058.1K
Net income-1.54M-23.1M-3.60M-78.3K-96.9K-332.0K-208.0K-47.3K-81.4K9.42K
Earnings per share, basic0.00-0.03-0.010.000.00-0.00-0.00-0.000.00
Earnings per share, diluted0.00-0.03-0.010.000.00

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2015
Cash and equivalents69.4K58.4K125.4K67624.4K93.9K38.0K3.13K6.58K
Receivables39.7K15.0K104.6K985971
Inventory106.9K111.1K217.5K653.3K850.3K
Current assets251.3K307.8K652.7K67624.4K94.8K38.0K3.01K6.58K
Property, plant and equipment159.7K200.7K13.7K
Goodwill0
Total assets411.0K508.5K865.8K59.1K127.8K367.7K91.8K61.6K101.8K
Accounts payable616.0K427.5K241.7K19.7K12.0K33.1K71.0K12.9K38.1K
Current liabilities4.07M3.63M2.79M64.9K14.2K41.5K77.5K75.6K73.0K
Long-term debt181.8K254.6K0195.8K197.8K148.5K
Total debt1.19M1.14M200.0K200.0K200.0K150.0K
Total liabilities4.95M3.89M2.94M260.7K212.0K190.1K77.5K75.6K73.0K
Shareholders' equity-4.54M-3.38M-2.07M-2.53M-84.2K177.6K14.2K45.5K28.8K
Shares outstanding969.0M957.0M770.8M269.7M956.6M268.0M265.7M1.60B1.60B

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations39.0K-324.1K-1.52M-64.7K-119.5K-94.1K-142.3K-56.7K
Capital spending-9.06K-189.4K00-31.5K000
Free cash flow29.9K-513.5K-1.52M-64.7K-151.1K-94.1K-142.3K-56.7K
Cash from investing-59.1K-187.9K-199.4K00
Cash from financing33.1K442.1K1.20M41.0K50.0K150.0K177.2K58.8K
Change in cash11.0K-67.0K-491.3K-23.7K-69.5K55.9K34.8K3.01K

Open Financials

Cap table

Built by 6ix from BioRegenx, Inc’s releases

Common shares
971,575,183
Fully diluted
971,575,183

Fully diluted

LineShares
Common shares971,575,183

Share count over time

CountShares
Nov 22, 2026971,575,183

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Richard Janney
Other companies: Skye Bioscience, Inc. (Principal Accounting Officer · Sep 25, 2020 – Sep 25, 2020 · Past); Asyst Technologies Inc (Interim CFO and interim PAO · Sep 25, 2006 – Sep 25, 2006 · Past)
Strategic CFO & Board Member · Since at least Oct 7, 2024
Diane BouisActing CEO MVHS · Since at least Nov 4, 2026
Gary HennerbergSecretary · Since at least Mar 8, 2024
Gary KissDirector · Mar 8, 2024 – Mar 8, 2024 · Past
Jody Marie WalkerDirector · Mar 8, 2024 – Mar 8, 2024 · Past
Robert DoranExecutive Vice President, Director · Mar 8, 2024 – Mar 8, 2024 · Past
Sherri AdamsChief Operating Officer, Director · Mar 8, 2024 – Mar 8, 2024 · Past
Suzanne BirdDirector · Since at least Mar 8, 2024
Thomas PowersDirector · Since at least Nov 5, 2026
William ResidesCHIEF EXECUTIVE OFFICER AND CHAIRMAN OF THE BOARD, BIOREGENX AND NULIFE SCIENCES & DIRECTOR · Since at least Mar 8, 2024

Open People

Log in to ask 6ix AI your own questions about BioRegenx, Inc.